Dr. Grace John-Stewart, a professor of global health, epidemiology, medicine, and pediatrics at the University of Washington, was recently awarded an $828,368 grant from the National Institutes of Health and the US Department of Health and Human Services. The grant is titled “The effect of HIV exposure and infection on immunity to TB in children”.
Globally, less than half of all people living with HIV (PLHIV) have achieved viral suppression. Delays with laboratory testing in resource-limited settings continue to present challenges for monitoring treatment with antiretroviral therapy (ART).
The UW/Fred Hutch Center for AIDS Research (CFAR) is delighted to announce this year's International Pilot Awards. The International Pilot Awards are for development and implementation of innovative and collaborative HIV-related research projects in developing countries by junior faculty. Awardees are funded up to $15,000 over one year.
Midway into a study in which all participants are offered use of a monthly vaginal ring containing an antiretroviral (ARV) drug called dapivirine, researchers have seen women's risk of acquiring HIV reduced by more than half.
By Sabrina Richards / Fred Hutch News Service
By Molly Walker / MedPage Today
Certain types of vaginal bacteria were associated with an increased risk of HIV infection among women, a nested case-control study of African women found.
By Matthew Sedacca
In recent years scientists studying genital microbiomes have focused on the possible connection between HIV incidence in men and the penile microbiome, the community of microorganisms living on the penis.
In Nigeria, anti-gay laws can lead to punishments including 14 years in prison or even death by stoning. Gay men and women are banned from holding meetings or organizing in groups, and anyone who supports the union of a gay couple could spend a decade behind bars.
By Lauran Neergaard
Creating new HIV prevention tools for women has proven frustratingly slow and researchers have found another hurdle: bacteria in the reproductive tract.
A new study published Thursday examined what stalled an early attempt at an anti-HIV gel, and found certain types of vaginal bacteria broke down the protective medication before it had time to work.